Clinically tested and proven In a recent 10-week clinical trial, participants experienced significant improvements in weight loss, digestion, energy, and appetite control.* 83% lost weight within 10 weeks 82% reduced food cravings within the first week 90% saw significant relief from bloating by week two 83% reported higher energy levels by week three *Clinical results are based on a self-reported survey conducted over 10 weeks with ColonBroom Premium
Shaik Mohamed Sayed UF, Moshawih S, Goh HP, Kifli N, Gupta G, Singh SK, et al
Increased potency and stability means less IGF-1 LR3 is needed compared to unmodified IGF-1
The 200mg dose of tributyrin is within the standard 150-300mg range considered to be both safe and effective,2 while the 1,680mg dose of pure butyrate (the highest among our recommendations) is high enough to help low-producing users compensate for their deficiency